Klas Therapeutics Limited

DataGardener
live
Micro

Klas Therapeutics Limited

ni676570•Private Limited With Share Capital

C/O Cleaver Fulton Rankin, 50 Bedford Street, Belfast, BT27FW
Website

Get Full Access

Visit WebsiteBook a Direct Call
Incorporated

16/02/2021

Company Age

5 years

Directors

4

Employees

5

SIC Code

72190

Risk

moderate risk

Company Overview

Registration, classification & business activity

Klas Therapeutics Limited (ni676570) is a private limited with share capital incorporated on 16/02/2021 (5 years old) and registered in belfast, BT27FW. The company operates under SIC code 72190 - other research and experimental development on natural sciences and engineering.

Private Limited With Share Capital
SIC: 72190
Micro
Incorporated 16/02/2021
BT27FW
5 employees

Financial Overview

Total Assets

£115.8K

Liabilities

£194.8K

Net Assets

£-78.9K

Cash

£70.6K

Key Metrics

5

Employees

4

Directors

6

Shareholders

Board of Directors

4
B
bridgeen callan
director
T
timothy john brundle
director
R
rubeta matin
director
J
john callan
director

Filed Documents

26
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:27-05-2026
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:24-02-2026
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-06-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-02-2025
Change Person Director Company With Change Date
Category:Officers
Date:24-02-2025
Resolution
Category:Resolution
Date:18-09-2024
Capital Allotment Shares
Category:Capital
Date:17-09-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:12-09-2024
Termination Director Company With Name Termination Date
Category:Officers
Date:10-05-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:26-02-2024
Capital Allotment Shares
Category:Capital
Date:20-02-2024
Capital Alter Shares Subdivision
Category:Capital
Date:20-02-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:19-02-2024
Memorandum Articles
Category:Incorporation
Date:19-02-2024
Memorandum Articles
Category:Incorporation
Date:19-02-2024
Resolution
Category:Resolution
Date:16-02-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-11-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:24-02-2023
Resolution
Category:Resolution
Date:20-02-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:16-12-2022
Capital Allotment Shares
Category:Capital
Date:17-11-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:17-11-2022
Gazette Filings Brought Up To Date
Category:Gazette
Date:11-05-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:10-05-2022
Gazette Notice Compulsory
Category:Gazette
Date:03-05-2022
Incorporation Company
Category:Incorporation
Date:16-02-2021

Innovate Grants

4

This company received a grant of £107602.0 for Product Optimisation Of A Novel New Melanoma Therapy Using Advanced Microscopy And Biomarkers To Enhance The Commercialisation Of This Technology.. The project started on 01/11/2023 and ended on 31/05/2025.

This company received a grant of £291086.0 for Klas Therapeutics Limited. The project started on 01/02/2024 and ended on 31/03/2025.

+2 more grants available

Risk Assessment

moderate risk

International Score

Future Factor

good

Performance Rating

Accounts

Typetotal exemption full
Due Date30/11/2027
Filing Date27/05/2026
Latest Accounts28/02/2026

Trading Addresses

48-50 Bedford Street, Belfast, BT27FWRegistered

Related Companies

10
sonotarg holdings limited
live
animotive limited
live
sisaf ltd
live
inclutech ltd
live
sonotarg limited
live
calo scientific ltd
live
causeway chemicals ltd
live
efectis uk/ireland limited
live
pulseai ltd
live
stimoxygen ltd
live

Contact

klastherapeutics.com
C/O Cleaver Fulton Rankin, 50 Bedford Street, Belfast, BT27FW